FRIDAY | March 7, 2025
13:00-13:30Get together and Welcoming Address
Francesco Zaja, UCO Ematologia Trieste
Roberto Di Lenarda, Rector Trieste University
13:30-15:00SESSION I | Myeloid Neoplasms-Biology
Chairmen:Heinz Sill (Graz - AUT)
Matevz Skerget (Ljubljana - SVN)
13:30-13:45NGS in acute myeloid leukemia - impact on therapy choice and prognosis
Mirta Mikulic (Zagreb - CRO)
13:45-14:00Gene expression analysis of autophagy markers in primary and secondary myelofibrosis
Marin Medjugorac (Zagreb - CRO)
14:00-14:15TP53 aberrations in myeloid neoplasms
Dutta Sayantanee (Graz - AUT)
14:15-14:30Leukemia Biobanking and its use for translational research
Armin Zebisch (Graz - AUT)
14:30-15:00Myeloid Neoplasms: Round Table Discussion, Common Interests & Potential Collaborations
15:00-16:45SESSION II | Myeloid Neoplasms-Clinic
Chairmen:Mario Tiribelli (Udine - ITA)
Andreas Reinisch (Graz - AUT)
15:00-15:15FLAG/FLAG-Idain R/R AML and new treatment modalities- single center experience
Sasa Anzej-Doma (Ljubljana - SVN)
15:15-15:30Non-classical risk factors for cardiovascular disease in MPN
Matjaz Sever (Ljubljana - SVN)
15:30-15:45Leveraging inflammation to combat acute myeloid leukemia
Philipp Jost (Graz - AUT)
15:45-16:00Clinical and molecular determinants of vascular events and progression in essential thrombocythemia
Luca Tosoni (Udine - ITA)
16:00-16:15Prognostic impact of mutational landscape on outcome to Venetoclax plus HMA in naïve unfit AML patients: a “real-life” experience
Eleonora De Bellis (Trieste - ITA)
16:15-16:45Myeloid Neoplasma: Round Table Discussion, Common Interests & Potential Collaborations
16:45-17:15Coffee break
17:15-17.35LECTURE I
Bispecific antibodies in the treatment of B-cell lymphomas: state of art
Umberto Vitolo (Candiolo - ITA)
17:35-19:20SESSION III | Lymphoid Neoplasms
Chairmen:Igor Aurer (Zagreb - CRO)
Samo Zver (Ljubljana - SVN)
17:35-17:50Venetoclax for treatment of CLL
Dino Dujmovic (Zagreb - CRO)
17:50-18:05Our experience with ixazomib in the treatment of myeloma
Ida Ivek (Zagreb - CRO)
18:05-18:20Teclistamab plus autologous lymphocytes in R/R MM; TALIM study
Francesco Zaja (Trieste - ITA)
18:20-18:35TCL and JAK2 mutation: case presentation
Aleksandar Boskovic (Ljubljana - SVN)
18:35-18:50The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergic Effect with Venetoclax
Alexander Deutsch (Graz - AUT)
18:50-19:20Lymphoid Neoplasms: Round Table Discussion, Common Interests & Potential Collaborations
SATURDAY | March 8, 2025
08:30-10:00SESSION IV | Benign Hematology & General Topics in Hematology
Chairmen:Francesco Zaja (Trieste - ITA)
Drazen Pulanic (Zagreb - CRO)
08:30-08:45Treatment of bleeding in a patient with von Willebrand disease and inhibitors to vWF
Ena Rankovic (Zagreb - CRO)
08:45-09:00ITP: from biology to new target therapies
Elisa Lucchini (Trieste - ITA)
09:00-09:15Secondary Hemophagocytic Lymphohistiocytosis and Hyperinflammation in Infectious Diseases - An underestimated Topic
Stefan Hatzl (Graz - AUT)
09:15-09:30Approach to and management of non-clonal erythrocytosis
Irena Zupan (Ljubljana - SVN)
09:30-10:00Benign Hematology & General Topics in Hematology: Round Table Discussion, Common Interests & Potential Collaborations
10:00-10:30Coffee break
10:30-10:50LECTURE II
Where are we moving?
Giorgio Minotti (Rome - ITA)
10:50-12:50SESSION V | Cellular Therapy (CAR-T, alloHSCT)
Chairmen:Renato Fanin (Udine - ITA)
Hildegard Greinix (Graz - AUT)
10:50-11:05CMV reactivation post alloHSCT in the era of prophylactic therapy
Lana Desnica (Zagreb - CRO)
11:05-11:20CAR-T cell blood level monitoring
Katarina Rebersek (Ljubljana - SVN)
11:20-11:35CAR-T patients’ monitoring: the laboratory side
Eleonora Toffoletti (Udine - ITA)
11:35-11:50Spatial distribution of immune cells in patients with steroid-refractory graftversus-host disease
Lukas Gaksch (Graz - AUT)
11:50-12:05Endothelial damage in aGvHD
Novak Polona (Ljubljana - SVN)
12:05-12:20What’s going on in allogeneic transplantation and cellular therapies: the Udine experience
Marta Lisa Battista (Udine - ITA)
12:20-12:50Cellular Therapy: Round Table Discussion, Common Interests & Potential Collaborations
12:50-13:00Closing remarks
Francesco Zaja (Trieste - ITA)